Global Radiation Dose Management Market -2024-2031

Global Radiation Dose Management Market -2024-2031


Global Radiation Dose Management Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031

The radiation dose management channel includes information on radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technology to reduce dose, including interactive reconstruction software. Also, radiation dose management is a critical aspect of medical procedures involving ionising radiation to ensure patient safety and optimise imaging outcomes.



Market Dynamics: Drivers & Restraints

Rise in advancements in radiation dose management

The market is witnessing major growth with the integration of artificial intelligence in radiology practices. Artificial Intelligence (Al) technologies are being increasingly used in various healthcare services, including radiology practices. Integration of artificial intelligence in imaging modalities can play a substantial role in this software. In addition, Al algorithms can help optimize imaging protocols by enhancing image reconstruction techniques and predicting individual-specific radiation doses.

For instance, according to the recent study published in Radiology, a journal of the Radiological Society of North America (RSNA), in July 2023, Al can use information from low-dose CT scans of the lungs to increase the risk prediction for death from lung cancer, CVD, and other causes. Moreover, as diagnostic imaging technology continues to progress, ongoing research and innovation will boost the outcomes of this software. This progress can lead to the development of novel tools, techniques, and methodologies for monitoring, measuring, and minimizing radiation dose exposure.

Furthermore, global radiation dose management are also driven by various other factors like a rise in the prevalence of chronic diseases, an increase in the number of diagnostic procedures and others helping the market to grow during the forecast period.

Lack of report tracking

Reporting can be challenging due to the need for automation from software to input data into radiologists' reports, communicate with referring physicians, and inform patients of exams and cumulative doses. Tracking doses beyond an individual facility or organization is also difficult. A cohesive record of a patient's imaging is crucial, as it should not be the sum of all imaging experiences.

For more details on this report – Request for Sample

Segment Analysis

The global radiation dose management market is segmented based on product type, modality, application, end-user and region.

The solutions from the product type segment accounted for approximately 54.1% of the radiation dose management market share

The solutions from the product type segment accounted for approximately 54.1%. Integrated solutions in radiation dose management are essential tools that not only automate dose registration and management but also contribute significantly to complying with radiation protection regulations, auditing imaging practices, and implementing optimization actions for enhanced patients.

For instance, in November 2023, Qaelum NV, a leading provider of innovative healthcare solutions, and Philips, a global leader in health technology, had a strategic partnership to revolutionize radiation dose management in medical imaging. This collaboration marks a significant milestone in the quest to enhance patient safety and optimize healthcare workflows.

The collaboration will leverage Qaelum's Dose, a state-of-the-art radiation dose monitoring solution, and Philips' advanced imaging systems to deliver comprehensive and integrated solutions for healthcare providers worldwide.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like high prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions, which necessitate frequent medical imaging procedures and radiation therapy treatments.

Also, the increasing incidence of chronic diseases drives the demand for radiation dose management solutions to optimize radiation doses, ensure diagnostic accuracy, and minimize radiation-related risks for patients undergoing imaging studies or radiation therapy.

For instance, in February 2024, Accuray Incorporated became the first in Canada to use its Radixact radiation therapy delivery system at Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital. The system aims to manage cancer while minimizing radiation dose to healthy tissue and associated side effects, as cancer diagnosis is reported every 8 minutes in Quebec. A second Radixact System is expected to be installed in mid-2024.

Covid 19 Impact Analysis

The COVID-19 pandemic severely disrupted healthcare services, leaving some areas unaffected, particularly CT scans. The COVID-19 pandemic had a positive impact on CT scans were the most commonly used tool for COVID-19 diagnosis due to their higher specificity and limitations compared to RT-PCR. The increasing importance of CT scans during the pandemic underscores their versatility.

Market Segmentation

By Product Type
• Solutions
Integrated Solutions
Standalone Solutions
• Services
Support and Maintenance Services
Consulting and Training Services
Others

By Modality
• CT Diagnostic Scans
• X-Ray Diagnostic Scans
• Interventional Procedures
• Nuclear Medicine
• Radiography and Mammography
• Molecular Imaging scans
• Others

By Application
• Oncology
• Cardiology
• Orthopedics
• Diagnostics
• Others

By End-User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Koninklijke Philips N.V., Bayer AG, GE Healthcare, Siemens Healthineers AG, Canon Medical Systems Corporation, Qaelum N.V., Medsquare SAS, PACSHealth LLC, Sectra AB, Agfa-Gevaert N.V among others.

Why Purchase the Report?
• To visualize the global radiation dose management market segmentation based on product type, modality, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of the radiation dose management market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global radiation dose management market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in advancements in radiation dose management
4.1.1.2. Rise in the prevalence of chronic diseases
4.1.2. Restraints
4.1.2.1. Lack of report tracking
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Solutions*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services
8. By Modality
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. CT Diagnostic Scans*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. X-Ray Diagnostic Scans
8.4. Interventional Procedures
8.5. Nuclear Medicine
8.6. Radiography and Mammography
8.7. Molecular Imaging scans
8.8. Others
9. By Application
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Oncology*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cardiology
9.4. Orthopedics
9.5. Diagnostics
9.6. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Specialty Clinics
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. South Korea
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Koninklijke Philips N.V.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Bayer AG
13.3. GE Healthcare
13.4. Siemens Healthineers AG
13.5. Canon Medical Systems Corporation
13.6. Qaelum N.V.
13.7. Medsquare SAS
13.8. PACSHealth LLC
13.9. Sectra AB
13.10. Agfa-Gevaert N.V
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings